Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
McKinsey
Boehringer Ingelheim
Mallinckrodt
Baxter

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Gp-pharm Sa Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for GP-PHARM SA, and what generic alternatives to GP-PHARM SA drugs are available?

GP-PHARM SA has one approved drug.

There is one US patent protecting GP-PHARM SA drugs.

There are fourteen patent family members on GP-PHARM SA drugs in twelve countries.

Summary for Gp-pharm Sa
International Patents:14
US Patents:1
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Gp-pharm Sa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gp-pharm Sa LUTRATE DEPOT KIT leuprolide acetate FOR SUSPENSION;INTRAMUSCULAR 205054-001 Aug 28, 2018 DISCN Yes No 9,789,064   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
McKinsey
McKesson
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.